Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges Sachem Capital Corp SCCF Q4 2025 Earnings Massive EPS Beat on Minimal Expectations PEBK Q4 2025 Earnings EPS of 121 Surpasses Absent Estimates Shares Edge Higher MBINN Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Lower FICO Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Scoring Business STNE Q1 2026 Earnings EPS Misses Estimates Stock Slips as Growth Concerns Emerge